Patients with nonalcoholic fatty liver disease (NAFLD) and advanced liver fibrosis are at the
highest risk for progressing to end‐stage liver disease. We constructed and validated a …

The biochemical response to ursodeoxycholic acid (UDCA)—so‐called “treatment
response”—strongly predicts long‐term outcome in primary biliary cholangitis (PBC) …

We describe two females, 15 and 23 years old, respectively, who presented with classical
features of Wilson's disease (WD) and several features of autoimmune hepatitis (AIH). The …

Background Treatment guidelines recommend a stepwise approach to primary biliary
cholangitis: all patients begin treatment with ursodeoxycholic acid (UDCA) monotherapy and …

Ursodeoxycholic acid is a dihydroxy bile acid with a rapidly expanding spectrum of usage in
acute and chronic liver diseases. The various mechanisms of action of this hydrophilic bile …

Objectives: Amebic liver abscess (ALA) is being increasingly recognized with the
progressive spread of AIDS. The prognosis of ALA needs to be determined to decide …

Prisoners have a high prevalence of hepatitis C virus (HCV), but case‐finding may not have
been cost‐effective because treatment often exceeded average prison stay combined with a …

Background & Aims Genome-wide association studies in primary biliary cholangitis (PBC)
have failed to find X chromosome (chrX) variants associated with the disease. Here, we …

Abstract Background & Aims There is limited information regarding patients with AIH outside
relatively few large centres. We describe here the presenting features of patients with AIH …

Results. A total of 1190 adult patients received OLTX in our center between 1982 and 1998.
A total of 77 patients (6.5%) were transplanted for AIH and 12 (15.6%) patients from this …